• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 26, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2121-12
Classification Class III
Code Info 4040029292, 4040029296, 4040029301, 4040029294, 4040029304, 4040029297, 4040029289, 4040029298, 4040029299, 4040029305, 4040035505, 4040035512, 4040035517, 4040035522, 4040035523, 4040030105, 4040029306, 4040030109, 4040030111, 4040030114, 4040030115, 4040030116, 4040030117, 4040030118, 4040030225, 4040030228, 4040030232, 4040030302, 4040030306, 4040030308, 4040030309, 4040030310, 4040030311, 4040030312, 4040030313, 4040030314, 4040030315, 4040030316, 4040030317, 4040030318, 4040030319, 4040030320
Product Distributed Qty 42 units
Reason For Recall Blood products, which may have reached unacceptable temperatures during storage, were distributed.

Event Detail

Event Id 42282
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma
City Lexington
State KY
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2006-05-15
Initial Firm Notification of Consignee or Public E-Mail
Distribution Pattern IL, Germany
-
-